tiprankstipranks
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
US Market
CNTB
Connect Biopharma Holdings
RESEARCH TOOLSreports

Connect Biopharma Holdings (CNTB) Stock News & Sentiment

145 Followers
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
Premium
Ratings
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
4d ago
CNTB
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
Premium
Ratings
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
4d ago
CNTB
Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results
Premium
Company Announcements
Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results
5d ago
8K
CNTB
CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11d ago
CNTB
Connect Biopharma announces board resignation amid U.S. transition
Premium
Company Announcements
Connect Biopharma announces board resignation amid U.S. transition
3M ago
8K
CNTB
Connect Biopharma Reports Significant Loss Amid Development Efforts
Premium
Company Announcements
Connect Biopharma Reports Significant Loss Amid Development Efforts
5M ago
CNTB
Promising Outlook for Connect Biopharma Holdings Driven by Rademikibart’s Potential and Strategic Partnerships
Premium
Ratings
Promising Outlook for Connect Biopharma Holdings Driven by Rademikibart’s Potential and Strategic Partnerships
5M ago
CNTB
More CNTB News >

CNTB News on the Web

Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
rttnews
Neutral
Major Insider Move Signals Strong Confidence in Connect Biopharma’s Future
TipRanks News
Bullish
Connect Biopharma director buys $4.0M in common stock
TipRanks News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)
TipRanks News
Bullish
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
TipRanks News
Bullish
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Connect Biopharma Holdings (CNTB), Neumora Therapeutics, Inc. (NMRA) and Merck & Company (MRK)
TipRanks News
Bullish
Connect Biopharma Shares Jump 13% After Positive Rademikibart Data And $20.2 Million Financing
rttnews
Bullish

News Score - Last 7 Days

Very Positive
CNTB
Sector Average
Media Buzz
This Week10 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CNTB’s Media Buzz Sentiment?
10 articles about CNTB were published this week. In an average week, 2.75 articles are published.
    What is CNTB’s weekly average amount of articles?
    In an average week, 2.75 articles about CNTB are published.
      What is CNTB’s News Sentiment?
      100% of articles about CNTB were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        OMEROmeros
        AGIOAgios Pharma
        2273Gushengtang Holdings Limited
        LTRNLantern Pharma
        CNTBConnect Biopharma Holdings
        Showing the stocks with the most bullish news sentiment over the past week